Motion Sickness Desensitization Using VR
SENSORIEL1
Evaluation and Countermeasures of Motion Sickness by Virtual Reality Desensitization Protocol
1 other identifier
interventional
30
1 country
2
Brief Summary
Evaluation of a virtual reality desensitization protocol on subjects with severe motion sickness and study of the role of the emotional component on the effectiveness of the therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2018
CompletedFirst Submitted
Initial submission to the registry
September 8, 2022
CompletedFirst Posted
Study publicly available on registry
November 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedNovember 28, 2022
August 1, 2022
5.1 years
September 8, 2022
November 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
motion sickness severity
simulator sickness questionnaire (0-64)
day 0 (day before the first session of rehabilitation)
motion sickness severity
simulator sickness questionnaire (0-64)
day 30 (day after the end of rehabilitation)
Secondary Outcomes (4)
Emotion
day 0 (day before the first session of rehabilitation)
Emotion
day 30 (day after the end of rehabilitation)
Posture
day 0 (day before the first session of rehabilitation)
Posture
day 30 (day after the end of rehabilitation)
Study Arms (1)
Cohort of motion sickness
OTHERone group of patient
Interventions
rehabilitation through using session of virtual reality desensitization
Eligibility Criteria
You may qualify if:
- Suffering from motion sickness inducing a functional disability requiring a change in the mode of travel, or suffering from motion sickness disabling to exercise a leisure or professional activity involving a mode of locomotion.
You may not qualify if:
- Pregnant woman
- History of severe ENT or ophthalmologic pathologies.
- Chronic treatment with an anticholinergic or anti-histamine medication.
- Participating in another biomedical research protocol during the same period
- Person under guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Caen University Hospital
Caen, 14033, France
Frédéric Xavier
Vitrolles, 13127, France
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
stephane BESNARD, Md,PhD
University Hospital, Caen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2022
First Posted
November 28, 2022
Study Start
January 10, 2018
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
November 28, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share